SEC Form 4 · accession 0001061983-17-000046
CYTOKINETICS INC · CYTK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Caryn Gordon McDowell
Officer — GC & Chief Compliance Officer
Period of report
Aug 8, 2017
Accepted (ET)
Aug 10, 2017 · 7:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001061983
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 8, 2017 | M | 1,391 | $6.67 | A | 21,570 | D | |
| Common Stock | Aug 8, 2017 | S | 300 | $12.35 | D | 21,270 | D | |
| Common Stock | Aug 8, 2017 | M | 2,736 | $6.67 | A | 24,006 | D | |
| Common Stock | Aug 8, 2017 | S | 500 | $12.375 | D | 23,506 | D | |
| Common Stock | Aug 8, 2017 | M | 5,411 | $6.37 | A | 28,917 | D | |
| Common Stock | Aug 8, 2017 | S | 3,200 | $12.40 | D | 25,717 | D | |
| Common Stock | Aug 8, 2017 | S | 800 | $12.425 | D | 24,917 | D | |
| Common Stock | Aug 8, 2017 | S | 2,300 | $12.45 | D | 22,617 | D | |
| Common Stock | Aug 8, 2017 | S | 200 | $12.475 | D | 22,417 | D | |
| Common Stock | Aug 8, 2017 | S | 300 | $12.50 | D | 22,117 | D | |
| Common Stock | Aug 8, 2017 | S | 700 | $12.625 | D | 21,417 | D | |
| Common Stock | Aug 8, 2017 | S | 500 | $12.65 | D | 20,917 | D | |
| Common Stock | Aug 8, 2017 | S | 538 | $12.70 | D | 20,379 | D | |
| Common Stock | Aug 8, 2017 | S | 200 | $12.725 | D | 20,179 | D | |
| Common Stock | Aug 8, 2017 | S | 1,810 | $12.45 | D | 18,369 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy) | $6.37 | Aug 8, 2017 | M | 5,411 | D | May 29, 2016 | May 29, 2025 | Common Stock | 5,411 | 24,589 | D |
| Incentive Stock Option (right to buy) | $6.67 | Aug 8, 2017 | M | 2,736 | D | Mar 23, 2016 | Feb 23, 2026 | Common Stock | 2,736 | 26,782 | D |
| Non-Qualified Stock Option (right to buy) | $6.67 | Aug 8, 2017 | M | 1,391 | D | Mar 23, 2016 | Feb 23, 2026 | Common Stock | 1,391 | 4,091 | D |
Explanation of responses
- F1The exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017.
- F2The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017.